Feinberg’s “pipeline programs” help underrepresented high school and undergraduate students explore and prepare for careers in medicine and science.
A new study shows that a neurodegenerative syndrome in older adults, frontotemporal dementia, shares several fundamental features with another neurodegenerative disease usually seen in children.
Computational Research Day brought together faculty members, investigators and students throughout Northwestern to showcase innovative research projects, share insights and tools, and strengthen the computational research community.
Feinberg’s Office of Admissions hosted the annual Second Look event, showcasing Feinberg’s curriculum and campus for prospective medical students in the class of 2021.
A study sheds new light on the molecular foundations of human acral lentiginous melanoma, a rare sun-shielded melanoma.
Feinberg medical students recently traveled to Atlanta, participating in the Student National Medical Association’s annual Medical Education Conference, in order to support health equity efforts and to help recruit a diverse student body.
In the vast majority of cases, urinary tract infections (UTIs) don’t spread to the kidneys, according to Dr. Sarah Flury, a urologist at Northwestern University. There are about 6 million urinary tract infections each year in the United States and about 250,000 kidney infections, Flury added.
Some also question the effectiveness of such testing. Rex Chisholm, vice dean for scientific affairs at Northwestern University’s Feinberg School of Medicine, said he’s a believer in pharmacogenomic testing, but it’s important to move carefully when rolling out such testing widely. Northwestern also has been running a study on pharmacogenomic testing. “It’s always a judgment call about how early in a new technology and development … do you actually want to be an adopter,” Chisholm said. “We want to have some additional evidence before we would go full-out and offer it to all our patients.”
Side effects from steroids are also possible but rare, according to Dr. Jeffrey Linder of Northwestern University School of Medicine in Chicago. “They include increased blood pressure, increased blood sugar, fluid retention,” he said. “They could be significant for people at risk for diabetes complications and at risk for cardiovascular disease,” said Linder, chief of the division of general internal medicine and geriatrics. Linder, who wasn’t involved in the research, noted that only about one-third of the steroid takers in the study actually got better within two days. “This is a well-done study and again, it is negative. I don’t think patients go to the doctor expecting to get a treatment that is only going to give them a 1 in 3 chance of complete resolution of their symptoms within two days,” he said.
The guidelines “highlight many, many important similarities much more than it highlights some small differences,” said Dr. Don Lloyd-Jones, a spokesperson for the AHA and a professor of preventive medicine at Northwestern University Feinberg School of Medicine. “Both guidelines start with the same concepts,” he said. “The difference is how they look at the evidence.” “We’ve seen a number of groups in which (the risk calculator) performs extremely well,” said the Heart Association’s Lloyd-Jones. Lloyd-Jones said that the current risk estimator was “a huge step forward” in that it accounts for women and African Americans, who have often been overlooked in large-scale health surveys. The 7.5% threshold used by the AHA is based heavily on clinical trial data, he said. “These risk scores were never intended to be perfect,” Lloyd-Jones said. “They’re there to start a conversation, not to write a prescription.” “The purpose of the ACC/AHA, the purpose of USPSTF is not to create a healthy pharmaceutical industry. It’s to create better care for our patients,” Lloyd-Jones said.